CLEC4M: A versatile protein for drug development and disease diagnosis

Target Name: CLEC4M

NCBI ID: G10332

CLEC4M

CLEC4M: A versatile protein for drug development and disease diagnosis

CLEC4M, or C-type lectin domain family 4 member M, is a protein that is expressed in a variety of tissues throughout the body. It is a type of transmembrane protein that is characterized by its ability to interact with various carbohydrates, including bacteria, viruses, and carbohydrates found in the cell surface.

One of the unique features of CLEC4M is its ability to recognize and interact with multiple carbohydrates simultaneously, making it a potentially useful protein for drug development. The ability to target multiple carbohydrates also makes it a promising biomarker for certain diseases.

CLEC4M is a member of the C-type lectin domain family, which is a common structural feature found in proteins that play important roles in cell signaling and interactions. The C-type lectin domain is responsible for the protein's ability to interact with carbohydrates, as well as other important cell signaling molecules.

One of the key functions of CLEC4M is its ability to recognize and interact with carbohydrates on the cell surface. This is accomplished through the protein's carbohydrate-binding module, which is located at the base of the protein and is responsible for the protein's ability to interact with carbohydrates.

The carbohydrate-binding module of CLEC4M is composed of multiple domains, including an N-terminal alpha-helix, a line-1 domain, and a C-terminal alpha-helix. The N-terminal alpha-helix is ??????responsible for the protein's ability to form a monomeric species, while the C-terminal alpha-helix is ??????responsible for the protein's ability to form adimeric species.

In addition to its ability to recognize and interact with carbohydrates, CLEC4M also has several other unique functions. For example, it is involved in the development and maintenance of the endoplasmic reticulum, which is the membrane-bound system responsible for the transport of proteins from the ER to the cell surface.

CLEC4M is also involved in several cellular signaling pathways, including the regulation of inflammation and the response to infection. For example, the protein has been shown to play a role in the regulation of inflammation, and is also involved in the response to bacterial infection.

Due to its multiple functions and its potential as a drug target, CLEC4M is an attractive target for drug development. Studies have shown that inhibiting the activity of CLEC4M has the potential to treat a variety of diseases, including cancer, infection, and inflammation.

In conclusion, CLEC4M is a protein that is characterized by its ability to interact with multiple carbohydrates and its involvement in several cellular signaling pathways. Its unique properties make it a potentially useful protein for drug development, and its potential as a biomarker for certain diseases make it an important target for research and development.

Protein Name: C-type Lectin Domain Family 4 Member M

Functions: Probable pathogen-recognition receptor involved in peripheral immune surveillance in liver. May mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. Is a receptor for ICAM3, probably by binding to mannose-like carbohydrates

The "CLEC4M Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLEC4M comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets